The product of the pilE (also called fimH) gene 
Type 1 pili (fimbriae) are filamentous proteinaceous appendages expressed by several members of the family Enterobacteriaceae (11) . Type 1 pili mediate bacterial binding to a variety of eucaryotic cells through a mannose-sensitive interaction with a receptor on the eucaryotic cell surface (8, 12, 34) . Escherichia coli type 1 pili are about 5 nm wide and 1 to 2 Lm long. They are composed principally of a single protein subunit, pilin, arrayed in a helical fashion around a hollow core (13) .
Until recently, it was assumed that type 1 pili were composed exclusively of pilin monomers. However, work from a number of laboratories (1, 2, 13-15, 18, 21, 22, 24) has suggested that in addition to the pilin subunit there are at least three other minor components isolated with pili and assumed to be polymerized along with the pilin monomers during pilus biosynthesis (14, 18) . Exactly how these minor components are arranged in the pilus shaft has been the subject of some attention and speculation (2, 13, 20, 24, 25) .
Our laboratory has been particularly interested in one of the minor pilus components, the product of a gene we termed pilE (21, 22) , which has also been called fimH (1, 2, 15, 18) . The 31-kDa pilE product is necessary for type 1 piliated cells to bind to and agglutinate guinea pig erythrocytes (21, 22) . Biochemical evidence has suggested that the pilE gene product is a minor pilus component that is located at the tip of the pilus and that it may also be intercalated in the shaft (2, 13) . Recent evidence indicates that the pilE gene product acts directly as the agglutinin (17) . However, the binding activity of the pilE product may be influenced by adjacent pilus components, since mutations that abolish pilus assembly also abolish (21) or at least reduce (16) receptor binding. We thus cannot formally eliminate the role of the other pilus components in influencing binding.
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It was initially thought that the pilE gene product was required solely for erythrocyte binding (22) . However, subsequent work in our laboratory has revealed that, in addition to binding, pilus length is also influenced in some pilE mutants. Insertion mutations that fall in the 5' half of the pilE gene produce mutants that have long pili and fail to bind erythrocytes, whereas insertions toward the 3' end produce mutants that have normal-length pili but still fail to agglutinate erythrocytes. The insertions affecting length and binding had initially been attributed to the loss of a separate gene (pilF) whose product now appears to have resulted either from premature transcription termination of the pilE gene or breakdown of the pilE product. The association of a second phenotype (long piliation) with certain alleles of the pilE gene product suggests that this minor component influences pilus morphology as well as pilus binding.
During the isolation of insertion mutations in pilE, we also devised an enrichment procedure for isolating mutants with point lesions in pilE. The enrichment procedure was based upon early and puzzling observations that both pellicle formation and erythrocyte agglutination, carried out by type 1 piliated E. coli, are inhibited by the same compounds (11, 27, 28 (23) . Antibiotics were added as previously described (31) . Minimal medium was minA medium supplemented with amino acids as described by Miller (23) .
Genetic techniques. Generalized transduction with P1 vir was carried out as described by Miller (23) . Plasmid DNA was introduced into cells by transformation (19) or by linear transformation as previously described (33) .
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Construction of the 4)80d SuIII(supF) lysogen was accomplished by infecting strain 0RN168 with a UV-induced lysate of strain SuI (35) . Trp+ His' lysogens were selected on minimal medium after infection with various dilutions of the lysate. Lysogens formed by the lowest dilution of lysate were examined for the defective prophage and absence of the helper phage by using standard techniques (23) .
Mutagenesis of pORN142 (Table 1 , Fig. 1 ) by a mutT strain of E. coli (37) approximately 1,000 transformant colonies was grown in L broth overnight, and the plasmid DNA was extracted and purified by cesium chloride density centrifugation. Isolation ofpilE point mutants. Mutant alleles of pilE were detected in the following way: mutT-mutagenized, purified plasmid DNA was introduced into strain ORN134 (pilE'-kan recA13) by transformation. Transformants were inoculated directly into 1.5 ml of L broth containing 25 mM a-methylmannoside and ampicillin, and the culture was grown without shaking. Typically, ca. 8,000 individ%ial transformants were introduced into each culture. Twehty cultures were made per experiment, and each culture was passaged in the following way; after 48 h of growth, a sterile swab was touched to the surface of a culture and used to inoculate another tube containing the same medium. After three passages, a loopful of the culture was streaked onto an L-agar plate containing ampicillin, and 20 individual colonies were scored for the PilE-phenotype (full piliation but failure to agglutinate guinea pig erythrocytes). Only one PilEcolony was kept per tube. On average, 5 of the 20 tubes had at least one PilE-mutant. The range, in nine experiments, was 1 to 9 tubes of the 20. The lesions causing the PilEphenotype were confirmed as mapping to the plasmid by extracting the plasmid DNA and reproducing the mutant phenotype in ORN134 transformants.
Introduction of pilE alleles into the chromosome. Mutant alleles of pilE, originally isolated on the pORN142 plasmid, were introduced into the chromosome of a recBC sbcB mutant of E. coli as described previously (33 Fig. 1 ). The final strains used in this study (ORNiSS through ORN167) have TnS insertion 113 adjacent to a particular pilE allele and do not have TnJO.
Detection of piliation. Piliation was detected by using guinea pig erythrocytes and antiserum raised against purified pili as previously described (30) . For the assay of mutants bearing the mutT-induced mutations, comparisons were made with overnight static broth cultures of mutant and parental strains. Equal volumes of culture were compared for their ability to agglutinate guinea pig erythrocytes. These conditions ensured that similar numbers of cells were tested and that the physiological conditions of parental and mutant cultures were the same. Mutants with the PilE-phenotype agglutinate in antipili antiserum but do not agglutinate guinea pig erythrocytes (21, 22) .
Recombinant DNA techniques. Conditions for restriction endonuclease digestion, agarose gel electrophoresis, and isolation and ligation of DNA fragments were as described previously (30) (31) (32) .
Electron microscopy. Growth and treatment of cells for electron microscopy were as previously described (21, 22 
RESULTS
Enrichment of pilE mutants in static broth containing ao-methylmannoside. We developed the enrichment procedure described in Materials and Methods to favor the outgrowth of mutants that could form a pellicle (surface film) (7, 10, 28, 29) in medium containing a-methylmannoside, an analog of mannose that normally inhibits pellicle formation and erythrocyte binding (27) (28) (29) surface of static broth outgrow individuals that cannot participate in pellicle formation. Early results with insertion mutations established that the pilE gene product was needed for normal enrichment to take place (i.e., in the absence of a-methylmannoside) and that at least one class of mutants favored by the a-methylmannoside enrichment procedure had the PilE-phenotype (full piliation but failure to agglutinate guinea pig erythrocytes).
In the current protocol, a subclone of the pil region (carried on plasmid pORN142) containing the pilE gene and an adjacent TnS insertion was used as a target for mutT mutagenesis (Fig. 1) . The mutagenesis was designed to favor missense mutations by taking advantage of the AT-+CG transversions produced in mutT strains (3, 5, 37) . The parental pilE gene on the pORN142 plasmid normally complements a pilE'-kan insertion mutation in the chromosome of ORN134 to produce a hemagglutinating (PilE+) strain. However, after mutagenesis, introduction into the ORN134 strain, and a-methylmannoside enrichment, a high proportion of the isolates examined had the PilE-phenotype. A total of 48 pilE mutants were isolated by this procedure. In all 48 cases the PilE-phenotype was due to a lesion on the mutagenized plasmid.
Characterization of the pilE mutants. All of the 48 plasmids showed no signs of deletions or insertions and failed to restore hemagglutinating ability upon strain ORN134 containing the pilE'-kan insertion. The plasmids also failed to complement strain ORN140 carrying the pilEJO4: :TnS lesion (formerly called pilF104::TnS) (22) . The pilE104::TnS allele has the TnS insertion much nearer the 5' end of the pilE gene than the pilE'-kan insertion (22) . These results suggested that the mutant phenotype was conferred by a small lesion and did not result from an interaction of the plasmid-encoded mutant product with a possible partial product from the chromosomal allele.
Mapping of the lesions by complementation with pORN145 ( Fig. 1) (Fig. 2) .
Since it was necessary to score for the mutant phenotype to conclude that the mutant allele had been introduced, we took the precaution of examining the possibility that we were introducing spurious mutations into pilE. This was done by examining Kanr recombinants resulting from the introduction of the pilE205 (Ts) allele carried by pORN205 into the chromosome of ORN109. Earlier screening had revealed that pORN205 conferred a temperature-sensitive pilE phenotype upon ORN134; that is, ORN134(pORN134) was PilE+ at 31°C and PilE-at 42°C. Of the 50 PilE-recombinants resulting from the linear transformation of ORN109, all were found to be temperature sensitive. This suggested that the procedure for introducing the lesion was faithfully introducing the plasmid-encoded mutation into the chromosome. We examined the possibility that one (or more) of the chromosomal mutant alleles could be complemented by one (or more) of the 48 plasmid-encoded alleles. This was done by introducing each of the 48 plasmids into each of the 12 strains containing the chromosomal mutant pilE alleles and scoring for erythrocyte agglutination. There was no indication of complementation in any of the combinations.
Alleles of pilE causing aberrant pilus morphology. Each of the 12 by electron microscopy. Three phenotypic classes could be distinguished (Fig. 3) . Class I mutants had normal levels of piliation and normal-length pili. Class II mutants had longer pili but normal numbers. Class III mutants had dramatically fewer pili, but the pili that were present were very long. Of the 12 mutants, 9 were class I, 1 was class II, and 2 were class III mutants. The class II and III mutants are designated as such in Table 1 . All other chromosomal mutants listed in Table 1 are class I mutants.
Temperature-sensitivepilE mutation. As mentioned above, one of the 48 mutants exhibited a conditional temperaturesensitive phenotype. Strain ORN157, bearing the pilE205 (Ts) allele, was normally piliated at both 31 and 42°C (Fig. 4 ), but growth temperature had a dramatic effect upon the ability of the temperature-sensitive mutant to agglutinate guinea pig erythrocytes (Fig. 5) strong pellicle at 42°C but virtually no pellicle at 31°C in the presence of a-methylmannoside. We grew mutant, parental, and nonpiliated strains at 31°C, diluted them, mixed them pairwise in approximately equal proportions (each member of the pair was genetically marked by its ability to utilize maltose), and then let them grow together at 42°C. Cells participating in pellicle formation under these conditions were significantly impeded from passing through a 5-pumpore-size filter. By measuring the ratio of cells in the upper chamber of the filter apparatus before filtering and comparing it with the ratio on the filter after filtering, we obtained a relative measure of the types of cells participating in pellicle formation. In all cases tested, the pilE mutant individuals were found to form pellicles to the exclusion of the parental (set I, Table 2 ) and nonpiliated strains (set II, Table 2 ). This result indicated that pellicle formation may be effected via the intercellular interaction of pilE gene products.
DISCUSSION
The pilE gene product is a minor component of type 1 pili and is necessary for the mannose-sensitive agglutination of guinea pig erythrocytes by type 1 piliated E. coli. Insertion mutations that map to pilE abolish agglutinating ability without affecting the ability of the mutants to polymerize pilin monomers into pili (21) . In this paper we describe an enrichment procedure we devised to obtain 48 mutants with apparent point lesions, induced by mutT mutagenesis, that map to the pilE gene. All of these mutants could form pellicles in the presence of a-methylmannoside and failed to agglutinate erythrocytes. Further characterization of 12 of the mutants revealed an effect of some of the pilE lesions on pilus morphology. Experiments with one temperature-sensitive mutant suggested that intercellular interactions between pilE gene products facilitate pellicle formation.
It has been known for over 30 years that type 1 piliated E. coli form a pellicle (surface film) on the surface of static broth cultures (10) . Past literature attributes pellicle formation to the hydrophobic character of pili (reviewed in reference 11), and this characteristic would indeed seem to be a prerequisite for piliated cells to be at an air-water interfacealthough this might not explain the formation of the film. Oddly, pellicle formation is inhibited by the same compounds that inhibit the agglutination of erythrocytes by type 1 pili (11, 27, 28) . The likely connection between these two properties (pellicle formation and hemagglutination) suggested to us the enrichment procedure described herein. The enrichment resulted in the isolation of 48 pilE mutants that were indeed aberrant in erythrocyte binding. A major strength of the enrichment was that it demanded that the mutants still produce a phenotype (pellicle formation) associated with the pilE product. Consequently, we believe that all of the point mutants produce a pilE gene product, but one defective in erythrocyte binding.
In addition to conferring pellicle formation in the presence of a-methylmannoside and defective erythrocyte binding, some of the pilE lesions produced mutants that exhibited anomalous pilus number and morphology. However, since most of the mutants produced normal-looking pili, we think it likely that only extremely aberrant pilE products affect pilus morphology. Nevertheless, the study of such mutants may provide a clue to the manner of assembly of these supramolecular structures.
Apart from the mutants that conferred a change in pilus number and morphology, a temperature-sensitive mutant was identified. We employed this mutant as a tool to address the question of what cell surface component(s) the mutant pilus product bound in effecting pellicle formation. The results supported the idea that pilE gene products in pili on adjacent cells interact to form a pellicle, although this was not shown directly.
In conclusion, our mutant isolation indicated that both pellicle formation and erythrocyte binding are related through their dependence upon the pilE gene product. We suspect that the reason that ot-methylmannoside normally inhibits guinea pig erythrocyte agglutination as well as pellicle formation is because it blocks a region of the pilE molecule that is required for both processes. Consequently, if one isolates a mutant that is "blind" to the inhibitory effect of a-methylmannoside on pellicle formation, this same mutant is likely to be defective for erythrocyte binding. We hope that these mutants will prove useful in dissecting receptor-ligand interactions by defining regions of the pilE protein that are important in erythrocyte binding. In addition, we hope that some of the lesions we have isolated will prove useful in examining the steps in the biogenesis of pili. Clearly, some of the lesions have a dramatic effect on pilus number and morphology.
